Literature DB >> 31725076

The role of insomnia in the association between posttraumatic stress disorder and hypertension.

Allison E Gaffey1,2, Nancy S Redeker3, Lindsey Rosman2,4, Janet M Mullington5, Cynthia A Brandt1,6, Sally G Haskell1,7, Matthew M Burg1,2,8.   

Abstract

OBJECTIVE: Posttraumatic stress disorder (PTSD) is associated with incident hypertension. Although this relationship is poorly understood, PTSD is also associated with insomnia symptoms, which increases the risk for hypertension. Whether insomnia contributes to PTSD-associated risk for hypertension is unknown.
METHODS: We examined self-report survey and electronic health record data from 1109 participants in the Women Veterans Cohort Study (mean age: 43.8 ± 10.9 years; 52% women, 81% White) to assess the cross-sectional associations between PTSD symptom severity, recent symptoms of insomnia, and hypertension, defined as self-reported treatment for high blood pressure in the last year. Structural equation modeling was used to examine whether insomnia symptoms mediate the association between PTSD and hypertension.
RESULTS: PTSD symptom severity was associated with hypertension (r = 0.09, P < 0.001). PTSD symptom severity and hypertension were each associated with the insomnia symptoms difficulty falling asleep, difficulty staying asleep, and worry/distress about sleep problems (PTSD: rs = 0.58--0.62, P <  0.001; hypertension: rs = 0.07--0.10, P <  0.001). A latent variable derived from those symptoms mediated 9% of the association between PTSD symptom severity and hypertension (P = 0.02).
CONCLUSION: In this study of young and middle-aged Veterans, insomnia symptoms mediated the association between PTSD and hypertension. Difficulties falling asleep and maintaining sleep and related distress may be particularly deleterious for cardiovascular health in Veterans. Longitudinal data is required to further investigate the associations between PTSD, insomnia, and hypertension.

Entities:  

Mesh:

Year:  2020        PMID: 31725076      PMCID: PMC8176546          DOI: 10.1097/HJH.0000000000002311

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  39 in total

1.  Validation of self-reported chronic conditions and health services in a managed care population.

Authors:  L M Martin; M Leff; N Calonge; C Garrett; D E Nelson
Journal:  Am J Prev Med       Date:  2000-04       Impact factor: 5.043

2.  Obstructive Sleep Apnea and Posttraumatic Stress Disorder among OEF/OIF/OND Veterans.

Authors:  Peter J Colvonen; Tonya Masino; Sean P A Drummond; Ursula S Myers; Abigail C Angkaw; Sonya B Norman
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

3.  Newly reported hypertension after military combat deployment in a large population-based study.

Authors:  Nisara S Granado; Tyler C Smith; G Marie Swanson; Robin B Harris; Eyal Shahar; Besa Smith; Edward J Boyko; Timothy S Wells; Margaret A K Ryan
Journal:  Hypertension       Date:  2009-09-14       Impact factor: 10.190

4.  Prevalence, pharmacotherapy and clinical correlates of diagnosed insomnia among Veterans Health Administration service users nationally.

Authors:  Eric Hermes; Robert Rosenheck
Journal:  Sleep Med       Date:  2014-02-08       Impact factor: 3.492

Review 5.  Insomnia in United States military veterans: An integrated theoretical model.

Authors:  Jaime M Hughes; Christi S Ulmer; Jennifer M Gierisch; S Nicole Hastings; Matthew O Howard
Journal:  Clin Psychol Rev       Date:  2017-11-20

6.  Veterans Affairs Primary Care Provider Perceptions of Insomnia Treatment.

Authors:  Christi S Ulmer; Hayden B Bosworth; Jean C Beckham; Anne Germain; Amy S Jeffreys; David Edelman; Stephanie Macy; Angela Kirby; Corrine I Voils
Journal:  J Clin Sleep Med       Date:  2017-08-15       Impact factor: 4.062

Review 7.  Hyperarousal and insomnia: state of the science.

Authors:  Michael H Bonnet; Donna L Arand
Journal:  Sleep Med Rev       Date:  2009-07-28       Impact factor: 11.609

8.  Effects of comorbid diagnoses on sleep disturbance in PTSD.

Authors:  Gregory A Leskin; Steven H Woodward; Helena E Young; Javaid I Sheikh
Journal:  J Psychiatr Res       Date:  2002 Nov-Dec       Impact factor: 4.791

Review 9.  Recent Advancements in Treating Sleep Disorders in Co-Occurring PTSD.

Authors:  Peter J Colvonen; Laura D Straus; Carl Stepnowsky; Michael J McCarthy; Lizabeth A Goldstein; Sonya B Norman
Journal:  Curr Psychiatry Rep       Date:  2018-06-21       Impact factor: 5.285

10.  Change in sleep symptoms across Cognitive Processing Therapy and Prolonged Exposure: a longitudinal perspective.

Authors:  Cassidy A Gutner; Melynda D Casement; Karina Stavitsky Gilbert; Patricia A Resick
Journal:  Behav Res Ther       Date:  2013-10-07
View more
  4 in total

1.  Posttraumatic Stress Disorder, Antidepressant Use, and Hemorrhagic Stroke in Young Men and Women: A 13-Year Cohort Study.

Authors:  Allison E Gaffey; Lindsey Rosman; Matthew M Burg; Sally G Haskell; Cynthia A Brandt; Melissa Skanderson; James Dziura; Jason J Sico
Journal:  Stroke       Date:  2020-12-10       Impact factor: 7.914

2.  The risk factors for insomnia and sleep-disordered breathing in military communities: A meta-analysis.

Authors:  Yujia Huang; Jingzhou Xu; Siqi Zheng; Shuyu Xu; Yajing Wang; Jing Du; Lei Xiao; Ruike Zhang; Hao Wang; Yunxiang Tang; Tong Su
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

3.  Baseline Characteristics from the Women Veterans Cohort Study: Gender Differences and Similarities in Health and Healthcare Utilization.

Authors:  Allison E Gaffey; Matthew M Burg; Lindsey Rosman; Galina A Portnoy; Cynthia A Brandt; Casey E Cavanagh; Melissa Skanderson; James Dziura; Kristin M Mattocks; Lori A Bastian; Sally G Haskell
Journal:  J Womens Health (Larchmt)       Date:  2021-01-13       Impact factor: 3.017

4.  Effects of ambulatory blood pressure monitoring on sleep in healthy, normotensive men and women.

Authors:  Allison E Gaffey; Joseph E Schwartz; Kristie M Harris; Martica H Hall; Matthew M Burg
Journal:  Blood Press Monit       Date:  2021-04-01       Impact factor: 1.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.